3.5. QPI 5a: Patients with Non-Mucinous Epithelial Ovarian Cancer to Be Tested for Germline BRCA1/2 Testing; Target 90%. QPI 5b: Patients with Advanced High Grade Serous and Clear Cell Carcinoma on Histology to Be Tested for Tumour BRCA1/2 Testing; Target 90%. Here, BRCA1 is linked to clear cell adenocarcinoma.